tradingkey.logo

Catheter Precision Inc

VTAK

0.365USD

-0.065-15.12%
Close 06/13, 16:00ETQuotes delayed by 15 min
3.38MMarket Cap
LossP/E TTM

Catheter Precision Inc

0.365

-0.065-15.12%
More Details of Catheter Precision Inc Company
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
Company Info
Ticker SymbolVTAK
Company nameCatheter Precision Inc
IPO dateSep 27, 2018
Founded at2018
CEOMr. David A. Jenkins
Number of employees22
Security typeOrdinary Share
Fiscal year-endSep 27
Address1670 Highway 160 West
CityFORT MILL
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code29708
Phone19736912000
Websitehttps://www.ramed.com/
Ticker SymbolVTAK
IPO dateSep 27, 2018
Founded at2018
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. David A. Jenkins
Mr. David A. Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
194.18K
--
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
40.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Andrew Arno ,
Andrew Arno ,
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David A. Jenkins
Mr. David A. Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
194.18K
--
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
40.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Andrew Arno ,
Andrew Arno ,
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
278.00K
66.19%
All other countries
142.00K
33.81%
By Business
By Region
No Data
Shareholding Stats
Updated: Mon, Jun 2
Updated: Mon, Jun 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Jenkins Family Charitable Institute
5.56%
Armistice Capital LLC
1.99%
Jenkins (David A)
1.54%
Warberg Asset Management LLC
1.43%
FatBoy Capital LP
0.56%
Other
88.91%
Shareholders
Shareholders
Proportion
Jenkins Family Charitable Institute
5.56%
Armistice Capital LLC
1.99%
Jenkins (David A)
1.54%
Warberg Asset Management LLC
1.43%
FatBoy Capital LP
0.56%
Other
88.91%
Shareholder Types
Shareholders
Proportion
Corporation
6.12%
Hedge Fund
3.87%
Individual Investor
1.87%
Investment Advisor/Hedge Fund
0.43%
Venture Capital
0.35%
Other
87.35%
Institutional Shareholding
Updated: Tue, Mar 4
Updated: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
34
1.36M
13.26%
-1.65K
2024Q4
37
1.12M
13.97%
-215.80K
2024Q3
45
563.38K
38.63%
+376.14K
2024Q2
46
202.02K
23.51%
+5.34K
2024Q1
50
211.28K
24.77%
+47.42K
2023Q4
52
169.47K
25.10%
+5.69K
2023Q3
56
180.73K
31.24%
+30.19K
2023Q2
57
168.19K
29.83%
+996.00
2023Q1
61
185.84K
35.83%
+171.62K
2022Q4
62
8.84K
7.57%
+1.23K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Jenkins Family Charitable Institute
500.23K
5.4%
--
--
Dec 31, 2024
Armistice Capital LLC
129.16K
1.39%
-444.39K
-77.48%
Dec 31, 2024
Jenkins (David A)
32.99K
0.36%
--
--
Jan 29, 2025
Warberg Asset Management LLC
310.16K
3.35%
+243.16K
+362.93%
Dec 31, 2024
FatBoy Capital LP
70.97K
0.77%
--
--
Jan 29, 2025
Geode Capital Management, L.L.C.
7.54K
0.08%
+6.40K
+563.73%
Feb 28, 2025
XTX Markets LLC
23.88K
0.26%
+23.88K
--
Dec 31, 2024
Caruso (James Joseph)
178.00
0%
--
--
Nov 18, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Sep 21, 2022
Merger
50<1
Sep 21, 2022
Merger
50<1
Date
Type
Ratio
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Sep 21, 2022
Merger
50<1
Sep 21, 2022
Merger
50<1
Sep 21, 2022
Merger
50<1
Sep 21, 2022
Merger
50<1
Nov 16, 2020
Merger
25<1
Nov 16, 2020
Merger
25<1
View more
KeyAI